Authors:
SHAARI CM
FARBER D
BRANDWEIN MS
GANNON P
URKEN ML
Citation: Cm. Shaari et al., CHARACTERIZING THE ANTIGENIC PROFILE OF THE HUMAN TRACHEA - IMPLICATIONS FOR TRACHEAL TRANSPLANTATION, Head & neck, 20(6), 1998, pp. 522-527
Authors:
YALAMANCHILI K
ROSENWASSER RH
THOMAS JE
LIEBMAN K
MCMORROW C
GANNON P
Citation: K. Yalamanchili et al., FREQUENCY OF CEREBRAL VASOSPASM IN PATIENTS TREATED WITH ENDOVASCULAROCCLUSION OF INTRACRANIAL ANEURYSMS, American journal of neuroradiology, 19(3), 1998, pp. 553-558
Citation: N. Mucciardi et al., SUCCESSFUL CLINICAL OUTCOMES AND COST SAVINGS ASSOCIATED WITH A 12-HOUR IV CEFTIZOXIME REGIMEN, Formulary, 31(4), 1996, pp. 304-306
Authors:
ROSENWASSER RH
LIEBMAN K
MCMORROW CM
GANNON P
Citation: Rh. Rosenwasser et al., CURRENT STRATEGIES FOR ENDOVASCULAR MANAGEMENT OF CEREBRAL VASOSPASM, Journal of neurosurgery, 84(2), 1996, pp. 762-762
Citation: Gp. Sesin et al., TICARCILLIN-CLAVULANATE AS AN ALTERNATIVE TO IMIPENEM-CILASTATIN, American journal of health-system pharmacy, 52(21), 1995, pp. 2468-2469